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Clostridium species are both heroes and villains. Some cause serious human and animal diseases, those
present in the gut microbiota generally contribute to health and wellbeing, while others represent useful
industrial chassis for the production of chemicals and fuels. To understand, counter or exploit, there is a
fundamental requirement for effective systems that may be used for directed or random genome
modiﬁcations. We have formulated a simple roadmap whereby the necessary gene systems maybe
developed and deployed. At its heart is the use of ‘pseudo-suicide’ vectors and the creation of a pyrE
mutant (a uracil auxotroph), initially aided by ClosTron technology, but ultimately made using a special
form of allelic exchange termed ACE (Allele-Coupled Exchange). All mutants, regardless of the mutagen
employed, are made in this host. This is because through the use of ACE vectors, mutants can be rapidly
complemented concomitant with correction of the pyrE allele and restoration of uracil prototrophy. This
avoids the phenotypic effects frequently observed with high copy number plasmids and dispenses with
the need to add antibiotic to ensure plasmid retention. Once available, the pyrE host may be used to
stably insert all manner of application speciﬁc modules. Examples include, a sigma factor to allow
deployment of a mariner transposon, hydrolases involved in biomass deconstruction and therapeutic
genes in cancer delivery vehicles. To date, provided DNA transfer is obtained, we have not encountered
any clostridial species where this technology cannot be applied. These include, Clostridium difﬁcile,
Clostridium acetobutylicum, Clostridium beijerinckii, Clostridium botulinum, Clostridium perfringens, Clos-
tridium sporogenes, Clostridium pasteurianum, Clostridium ljungdahlii, Clostridium autoethanogenum and
even Geobacillus thermoglucosidasius.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The genus Clostridium have long been recognised as a large and
disparate grouping of bacteria that has representatives of impor-
tance to both human and animal diseases as well as to the industrial
production of chemicals and fuels. Whilst the majority of those
species responsible for human and animal diseases have been
known for decades, in recent years the importance of members of
the class clostridia in the gut microbiome has become ever more
apparent [1,2]. On the other hand, the desire to exploit an ever
widening diversity of species for biotechnological purposes hasup, BBSRC/EPSRC Synthetic
gham, University Park, Not-
.P. Minton).
r Ltd. This is an open access articleintensiﬁed. Of particular note, is the growing momentum behind
the industrialisation of gas fermentation for chemical and fuel
production using clostridial acetogens. Acetogenic bacteria, typiﬁed
by Clostridium autoethanogenum [3], are able to capture carbon (CO
or CO2) through gas fermentation, allowing them to grow on a
spectrum of waste gases from industry (eg., steel manufacture and
oil reﬁning, coal and natural gas) to produce ethanol [4,5]. They can
also consume ‘synthesis gas’ (CO and H2) made from the gasiﬁca-
tion of renewable/sustainable resources, such as biomass and do-
mestic/agricultural waste. Acetogenic gas fermentation can,
therefore, produce ethanol in any geographic region without
competing for food or land. Indeed, the commercialisation of
ethanol production from ArcelorMittal Steel Mill off-gas is now at
an advanced stage [6]. When fully scaled, it could enable the pro-
duction in Europe of around 500,000 tons of ethanol a year.
Intriguingly, Clostridium difﬁcile carries the pivotal genes requiredunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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to be able to grow on CO as a carbon source [7].
Given the increasing numbers of clostridial species that need to
be more thoroughly characterised, either to counter the diseases
they cause or to exploit their beneﬁcial properties, the imple-
mentation of genetic systems is required. Accordingly, SBRC Not-
tingham has formulated a roadmap for gene system development
in any clostridial species.
2. Roadmap basis
The roadmap revolves around exploitation of the dual, and
opposite, phenotypes conferred on the cell by mutant and wildtype
pyrE alleles. The presence of the former makes the host a uracil
auxotroph that is resistant (R) to ﬂuoroorotic acid (FOA), while the
latter confers sensitivity (S) to FOA but is a uracil prototroph. Se-
lective cycling between these two alleles allows recombination-
based genome editing by ‘knock-out’ (KO) and ‘knock-in’ (KI).
Importantly, the availability of amutant pyrE allelemay be used as a
locus for the rapid genome insertion of DNA for both comple-
mentation studies and for the insertion of application speciﬁc
modules. Using pyrEmutant hosts, therefore, presents considerable
advantages for all mutational studies, regardless of the mutagen
employed. Implementation of the roadmap is reliant on two
fundamental developments being in place, namely: (i) the avail-
ability of a fully annotated genome sequence, and; (ii) a means of
introducing DNA into the clostridial host.
2.1. Genome sequences
The availability of an annotated genome sequence is central to
gene system development, not only to identify gene targets, but
additional to assist in overcoming RM barriers (see 2.2). The closure
of whole genome sequences, however, is hindered by the presence
of long stretches of repetitive DNA which can prevent scaffold as-
sembly of the shorter DNA reads generated by commonly used
technologies, such as, Illumina MiSeq, Ion Torrent and 454 GS
FLX þ Titanium. In these cases, the read lengths generated
(100e1000 base pairs) are unable to cover the repetitive sequence
lengths of 5e7 Kb commonly found in bacteria [8]. Genome closure
therefore requires expensive and time consuming manual ﬁnish-
ing. PacBio have developed SingleMolecule Sequencing Technology
(SMRT) which is capable of generating read lengths in excess of
15 Kb [9] and currently, therefore, represents the technology of
choice for determining whole genomes. However, compared to
Illumina sequencing [10,11] the error rate for PacBio sequencing is
relatively high, particularly across homopolymer regions between
two and fourteen base pairs in length [11]. Accordingly, it is
advisable to combine PacBio sequencing with Illumina sequencing,
mapping the latter reads to the PacBio-derived, reference assembly.
Following the correction of any errors in the determined closed
genome, it can be submitted to one of a number of online facilities
for automated annotation. For example, the Integrated Microbial
Genomes (IMG) system at DOE’s Joint Genome Institute (JGI) pro-
vides such an annotation service (https://img.jgi.doe.gov/cgi-bin/
mer/main.cgi).
It should be noted, that in those instances where the genome
sequence of the clostridial species being used is published, the
assumption should not be made that the sequence is correct. For
instance, the ﬁrst clostridial genome sequence to be determined
(that of Clostridium acetobutylicum ATCC 824 [12], was recently
shown to contain numerous errors in the form of 175 Single
Nucleotide Variations (SNVs) and 48 insertions/deletions (Indels).
Similarly, the PacBio-derived genome sequence of Clostridium
autoethanogenum DSM 10061 (NCBI: GCA_000484505.1) wasshown to contain 243 SNVs [13]. It is equally important, not tomake
the assumption that the laboratory isolate being used has an
identical sequence to that published. SNVs and Indels can arise,
particularly if the strain has been passaged (intentionally or
otherwise) through single colonies. Thus, a strain of Clostridium
acetobutylicum ATCC 824 in common use in a number of European
laboratories (ATCC 824 COSMIC) was shown to possess 2 SNVs and
1 deletion in comparison to the strain deposited at the ATCC [13].
More telling are the changes identiﬁed in the erythromycin resis-
tance derivative, 630Derm, of the Clostridium difﬁcile strain 630.
These equated to 71 differences between the two strains, encom-
passing 8 deletions (including the Derm mutation), 10 insertions, 2
insertion-deletions, 50 substitutions and 1 region of complex
structural variation [14].
2.2. Restriction/modiﬁcation (RM) barriers
Prevention of DNA transfer by host RM systems is highly strain
speciﬁc. Indeed, there are many instances where restriction has not
been a problem, e.g. Clostridium beijerinckii NCIMB 8052 [15],
Clostridium perfringens strain 13 [16], C. difﬁcile strains CD37 [17] &
CD630 [18] and Clostridium botulinum ATCC 3502 [19]. Genome
sequencing has shown that many of these organisms carry at least
one type II methylase gene (most often more than one), but they
lack genes encoding the cognate restriction enzymes. Thus, for
instance, the genomes of C. botulinum ATCC 3502 (NC_009495) and
C. perfringens strain 13 (NC_003366) contain orphan copies of
methylase genes (three and one, respectively), and are both readily
transformable in the absence of any measures to circumvent re-
striction barriers [16,20]. In many instances, however, the suc-
cessful transfer of extrachromosomal elements, either by
transformation or conjugation, has required the circumvention of
the activity of endogenous restriction-modiﬁcation (RM) systems.
This is achieved through appropriatemethylation of the vector DNA
to be introduced. The nature and speciﬁcity of those enzymes
involved has been achieved in a variety of ways. In early work,
experimental approaches predominated in which restriction ac-
tivity was initially detected in bacterial lysates after which, the
restriction and the methylation speciﬁcity of the RM system was
determined and then countered through the deployment of an
appropriatemethylase activity in the Escherichia coli donorwith the
requisite speciﬁcity. Early examples include C. acetobutylicum ATCC
824 [21], Clostridium cellulolyticum ATCC 35319 [22], C. botulinum
ATCC 25765 [23] and C. difﬁcile CD3 and CD6 [17] andmore recently
Clostridium pasteurianum [24] and Clostridium cellulovorans [25].
In recent years, there has been an increasing emphasis on using
genome sequences to identify potential RM systems and using
available gene knock-out systems to inactivate the identiﬁed re-
striction systems. Thus, successful DNA transfer in C. cellulolyticum
was achieved by the inactivation of a putative MspI-like endonu-
clease gene, ccel2866 [26], while DNA transfer in C. acetobutylicum
ATCC 824 and DSM 1731 (essentially the same strain) in the absence
of methylation of the transferred plasmid was achieved by inacti-
vation of gene (CA_C1502) encoding type II restriction endonu-
clease Cac824I (recognition sequence GCNGC) using either
ClosTron mutagenesis [27] or allelic exchange [28]. In the latter
study, inactivation of a second gene encoding an additional type II
restriction enzyme (Cac824II e recognition sequence CTGAAG) led
to a further 8-fold increase in electroporation frequency [28]. A
similar approach [29] was undertaken to activate the previously
identiﬁed Type II restriction gene CpaAI (recognition sequence 50-
CGCG-30) in C. pasteurianum [24], dispensing with the need to
methylate plasmids in the E. coli donor using M. FnuDII methylase
prior to DNA transfer.
Whilst the majority of studies have focussed on Type II systems,
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systems can be negated by cloning into the E. coli donor both the
methylase and speciﬁcity subunits (HsdM and HsdS) of two type I
systems (RM1 and RM2) identiﬁed in Clostridium saccharobutylicum
NCP 262. The resultant protection of the mobilisable cloning vector
in the E. coli Top10 donor led to the successful transfer of a shuttle
vector to C. saccharobutylicum in a triparental mating using the
conjugative donor strain CA434 [30]. These same authors went on
to individually inactivate the hsdR components of RM1 and RM2
systems using ClosTronmutagenesis, achieving a 10-fold and 8-fold
increase in transfer frequencies, respectively.
In the past, the speciﬁcity of methylation systems was deter-
mined either by showing that homologous genes encoding meth-
ylases of known speciﬁcity protected the vector to be transferred
(eg. [11,18,21,22], or in the case of cytosine-speciﬁc methylases,
using a modiﬁcation of the method of Feil et al. [31], in which all
unmethylated cytosines are converted to uracil using sodium
bisulphite. Subsequent sequencing of NaHSO3-treated DNA propa-
gated in the target Clostridium reveals the identity of such cytosine
residues. The development of SMRT PacBio sequencing, however,
represents a step change in such determinations as it provides the
opportunity to directly identify methylation patterns in genomes,
both cytosine and adenosine methylation, for example in
C. pasteurianum [32,33] and C. difﬁcile [14]. Importantly, the PACBio
data obtained may be directly deposited in the REBASE PacBio
database (http://rebase.neb.com/cgi-bin/pacbiolist) [34], where the
necessary analysis is undertaken free of charge.
2.3. Establishment of gene transfer procedures
But for a brief dalliance with PEG-mediate protoplasts pro-
cedures (eg., [35]), only two methods are routinely pursued in
terms of obtaining DNA transfer to clostridial hosts, electroporation
and conjugative mobilisation from a shuttle host, invariably E. coli.
In terms of conjugative plasmid transfer, the method of choice is to
use conjugation between an E. coli donor and the clostridial
recipient. The majority of methods rely on the oriT-mediated
mobilisation of plasmids by the transfer functions of IncP plasmids,
either located autonomously (as in the host CA434, which carries
R702) or integrated in the genome (strain S17.1 or Sm10). The
commonest origin of transfer (oriT) employed is that of RK2.
Methods are largely based on the pioneering work ofWilliams et al.
[36], in C. acetobutylicum, later replicated in C. difﬁcile [17], although
in some instances an alternative oriT region from the broad-host
range transposon Tn916, has been used with certain strains of
C. difﬁcile [37]. In the case of electroporation, empirical changes are
made to a multitude of parameters to achieve the highest transfer
frequencies. These include preparing cells at different phases of
growth, including cell weakening agents in the media, the use of
different buffers for preparation of competent cells, and the
different electrical parameters of the electric pulse ampliﬁed, as
well as its duration (see Ref. [24] for a recent example).
2.4. Identiﬁcation of an appropriate ‘pseudo-suicide’ replicon
The allelic exchangemethodologies developed in this laboratory
are all reliant on replication defective plasmids [13,38,39]. When
such plasmids encode an antibiotic resistance gene, typically catP,
they are maintained within the cell by antibiotic selection, thiam-
phenicol (Tm). Under such situations, the rate of growth of the
population is determined by the rate at which the plasmid is
segregated to the daughter cells. If the plasmid is endowed with a
region of homology to the chromosome, then those rare cells in
which the plasmids integrate via homologous recombination now
have a growth advantage because every daughter cell carries a copyof the catP gene. The integrated sub-population, therefore, has a
growth advantage over those cells in which the plasmid remains
autonomous. This growth advantage manifests itself as visibly
larger colonies on agar media. We have termed such plasmids,
pseudo-suicide vectors [38,40]. It follows that an early stage in the
application of the roadmap to a particular clostridial species is to
determine the most defective replicon of those available. This un-
dertaking has been simpliﬁed by the creation of the pMTL80000
modular vector series [41].
The pMTL80000 vector series represent a standardised plasmid
set in which each module is localised to a deﬁned restriction
fragment bounded by one of four rare 8 bp palindromic sequences,
corresponding to the restriction recognition sites of the endonu-
cleases SbfI, AscI, FseI and PmeI [41]. Modules correspond to the
Gram-negative replication region (for maintenance in E. coli), the
Gram-positive replicon (for maintenance in clostridia), an antibi-
otic resistance gene (for selection in both E. coli and Clostridium),
and an application speciﬁc module (eg., reporter gene, promoter,
multiple cloning sites). These modules are always arranged in the
same order, viz., PmeI-SbfI (Gram-negative replicon), SbfI-AscI
(application speciﬁc module), AscI-FseI (Gram-positive replicon)
and FseI-PmeI (antibiotic resistance gene). At the time, 18 modules
were available, including 5 different Gram-positive replicons, those
of the plasmids pBP1 (C. botulinum), pCB102 (Clostridium butyr-
icum), pCD6 (C. difﬁcile) and pIM13 (Bacillus). The modules are
numbered to allow the easy identiﬁcation of the components
present in any particular plasmid. This system allows the combi-
natorial construction of shuttle plasmids from modules in the
standard format. It also provides for the quick and easy modiﬁca-
tion of existing pMTL80000-based plasmids. All of the pMTL allelic
exchange vectors, transposon vectors and ACE vectors described in
this review conform to this modular format. Moreover, numerous
other modules have been added to the system, including new
replicons. Updates can be found at http://chainbiotech.com/
modular-plasmids/.
To determine the most defective replicon, the vectors are
transferred to the target clostridial strain and their segregational
stability assessed. This can be determined either by measuring the
growth rate in the presence of antibiotic, or by growing in the
absence of antibiotic and then estimating the number of cells that
have lost the plasmid. The latter involves either plating cells on agar
media with and without antibiotic and comparing the cfu/ml, or by
plating onto media lacking antibiotics and then patch plating onto
agar media with and without antibiotic (Fig. 1). It should be noted
that aside from the different properties of replicons in the different
clostridial species, they can also show wide variation in different
strains of the same species. For example, plasmidsbasedon thepBP1
replicon are the least stable in the C. difﬁcile strain R20291, whereas
this represents the most stable replicon in strain 630 (see Fig. 1).
2.5. Generation of a ClosTron pyrE mutant to formulate FOA-
selective media
The pyrE gene encodes orotate phosphoribosyl transferase,
responsible for the conversion of the pyrimidine intermediate
orotic acid into orotidine 50-monophosphate (OMP). FOA is an
analogue of orotic acid and is converted by the same enzyme into 5-
ﬂuoroorotidine monophosphate (5-FOMP) which is subsequently
converted to 5-ﬂuorouridine monophosphate (5-FUMP), instead of
UMP. Accumulation of 5-FUMP is toxic and leads to cell death [42].
It follows that the inactivation of pyrE prevents the accumulation of
5-FUMP and therefore, confers on the host a FOAR phenotype.
The ﬁrst step of the roadmap is to generate a pyrEmutant using
ACE. The isolation of this mutant is facilitated by the fact that such
mutants become resistant to FOA. As it is not clear what FOA
Fig. 1. Relative stability of the various modular replicons in different species and strains of Clostridium. R ¼ Plasmid loss in media lacking supplementation with antibiotic as a
function of time and measured as loss of antibiotic resistance. Each replicon based plasmid is compared to the stability of a cell carrying the antibiotic gene in the chromosome. For
comparison, the projected rate of loss of a population carrying a plasmid that cannot replicate (‘Suicide’) is given.
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ClosTron technology to rapidly generate a pyrE mutant, and then
use that mutant to establish the FOA supplemented media required
to distinguish pyrE mutants from wild type. The ClosTron is one of
themost used clostridial gene knock-out systems and is a derivative
of the Sigma Aldrich Targetron system [43e45]. By making a
handful of nucleotide changes to the group II intron encoding re-
gion, the intron can be directed to insert into almost any region
within the genome. Through the use of a Retrotransposition-
Activated Marker (RAM) based on the ermB gene, successful
insertion is selected on the basis of acquisition of resistance to
erythromycin. The re-targeted region is designed using an online
re-targeting algorithm (www.clostron.com), and an order placed
with DNA2.0 for both the synthesis of the retargeted region AND its
custom cloning into the ClosTron vector. Re-targeted ClosTrons are
delivered ready for use in 10e14 days, allowing mutants to be
isolated 5e7 days after receipt. This dispenses with the need to
purchase Sigma Aldrich kits, or pay to use their algorithm.
Standard protocols [44e46] are deployed to implement Clos-
Tron technology in the chosen Clostridium, to generate a pyrE
(encoding orotate phosphoribosyl transferase) mutant, requiring
exogenous uracil. Once obtained, the concentration of FOA required
to select for pyrE minus cells is determined empirically. As pyrE
mutants are auxotrophic, the media also has to contain exogenous
uracil. Generally speaking, the level of exogenous uracil added is in
the range of 5e50 mg/ml, while the FOA supplementation can be as
lowas 800 mg/ml (C.beijerinckii) to as high as 3.5mg/ml (Clostridium
sporogenes).2.6. The use of ACE and the FOA-selective media to create a pyrE
deletion mutant
Having established the most defective Gram-positive replicon,
an ACE (Allele-Coupled Exchange) [47] vector is constructed using
this replication region based on the pMTL80000 modular format[41] to inactivate pyrE. Following integration of the ‘pseudo-suicide’
plasmid by single-crossover recombination, the system is designed
such that during the desired second recombination event, a
plasmid borne allele becomes ‘coupled’ to a genome located allele
which leads to the creation of a new selectable (in this case FOAR)
allele, allowing the isolation of double-crossover cells. The use of
highly asymmetric homology arms dictates the order of recombi-
nation events. A long, right homology arm (RHA) directs the ﬁrst
recombination event (plasmid integration) and a much shorter left
homology arm (LHA) directs the second recombination event
(plasmid excision). The ease and rapidity of ACE allows the
sequential extension of operon size and complexity through
repeated cycles of the method, as demonstrated through iterative
insertion of the entire lambda genome (48.5 kb) into the
C. acetobutylicum genome [47] as wells as synthetic mini-
cellulosome operons [48].
As indicated (section 2.7), following transfer of the ACE vector
into the cell, single cross-over integrants are selected based on
faster growing, larger colonies. Such integrants are invariably in-
tegrated via the LHA, due to its greater size compare to the RHA
[47]. These faster growing colonies are then streaked out onto
minimal media lacking thiamphenicol and supplemented with FOA
and uracil at the concentration determined (section 2.7) using the
ClosTronmutant. Those FOAR cells that arise will represent deletion
mutants in which the desired second crossover event has occurred
and the excised plasmid has been lost. Phenotypically they are,
therefore, FOAR, uracil minus and Tm sensitive (S). Their authen-
ticity is checked by using oligonucleotide primers that ﬂank the
pyrE gene to PCR amplify a DNA fragment, which in addition to
being of a smaller size compared to the wild type, is conﬁrmed to
encompass the expected deletion event by nucleotide sequencing.
2.7. Implementation of allelic exchange methodologies
As the pyrEmutant is now resistant to FOA, the introduction of a
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As such, the introduced gene can be used as a counter selection
marker. Accordingly, KO pseudo-suicide vectors can be constructed
carrying a suitable KO cassette (composed of equal sized homology
arms ﬂanking the gene to be inactivated), an antibiotic resistance
marker (catP), a heterologous (to avoid unwanted homologous
recombination) functional pyrE gene and the selected (section 2.4)
defective replicon. The plasmid is introduced into the cell and
clones in which the plasmid has integrated via homologous
recombination, between one or other of the two homology arms
and the corresponding complementary DNA in the chromosome,
selected on the basis of their larger colony size on agar media
supplemented with Tm. Selection and restreaking of the faster
growing colonies allows the isolation of single crossover integrants,
as determined by PCR screening using an appropriate combination
of primers complementary to regions ﬂanking the homology arms
and vector encoded sequences. The isolation of pure single cross-
over populations is essential as the presence of substantive sub-
populations of cells carrying autonomous plasmids can lead to
high counts of spurious mutants in the presence of the counter
selection agent.
Examples of the KO vectors constructed based on this principle
are pMTL-YN3 and pMTL-YN4, which are used for KO in C. difﬁcile
strain 630 and the PCR-ribotype 027 strain R20291, respectively
[39]. The former vector uses the pCB102 replicon [49], due to its
comparatively greater defectiveness in strain 630, while plasmid
pMTL-YN4 is based on the pBP1 repliconwhich is themost unstable
replicon in strain R20191. In the case of C. acetobutylicum ATCC 824,
the replicon of choice and the one used in the KO vector pMTL-ME3
[13] is that of pIM13. The heterologous pyrE gene used in the case of
both organisms was that of C. sporogenes ATCC 15579. Traditionally
KO cassettes may be individually generated (PCR) as separate Left
and Right Homology Arms (LHA and RHA) that are sequentially
cloned using created (part of the primer) restrictions sites into
corresponding vector restriction sites. Alternatively, they can be
commercially synthesized, as either the entire DNA fragment or, if
appropriately designed, they can be assembled from smaller frag-
ments using procedures such as G-Blocks [50], USER cloning [51],
ligase cycling [52] or Golden Gate [53]. Alternatively, the two DNA
fragments comprising the LHA and RHA may be joined prior to
cloning using Splicing Overlap Extension PCR (SOE) [54].
The robustness and reliability of the method was initially
demonstrated in C. difﬁcile through the creation of in-frame de-
letions in spo0A, cwp84, andmtlD in strain 630Derm and spo0A and
cwp84 in R20291 [39], and in C. acetobutylicum ATCC 824 the spo0A,
cac824I, amyP and glgA genes [13]. The procedure has proven
equally effective using the alternative negative selection marker
codA in both C. difﬁcile [39] and C. acetobutylicum [13]. This gene
encodes cytosine deaminase, (EC 3.5.4.1) which catalyzes the con-
version of cytosine to uracil. It also converts the innocuous py-
rimidine analogue 5-ﬂuorocytosine (FC) into the highly toxic 5-
ﬂuorouracil (FU). FU toxicity occurs as a result of the irreversible
inhibition of thymidylate synthase, a key enzyme in nucleotide
biosynthesis.
2.8. ACE correction vectors
Once the pyrE mutant is generated, an ACE correction vector is
constructed, designed to restore pyrE to wild type. In this instance,
following the isolation of a single crossover integrant, the desired
double crossover event is simply selected by plating on media
lacking uracil. That is to say, the auxotrophic mutant is converted
back to prototrophy. The nature of the deletion is such that
reversion to prototrophy cannot occur by any other means than
ACE-mediated replacement of the defective allele with a wild typeversion. In other words, there are no false positives. The proto-
trophic cells now become FOA sensitive (S). Crucially, the system
provides the in parallel opportunity to complement the mutant at
an appropriate gene dosage, through the insertion of a functional
wild type copy of the gene, into the genome, either under the
control of its native promoter or the strong Pfdx promoter (derived
from the ferredoxin gene of Clostridium sporogenes), concomitant
with restoration of the pyrE allele back to wild type [13,39]. The
extra effort involved in the deployment of ACE vectors compared
to the use of autonomous complementation vectors is minimal
(Fig. 2). They require the same amount of effort in terms of con-
struction and transfer into the desired bacterial host. Mutants
transformed with autonomous complementation plasmids need to
be puriﬁed by restreaking, whereas an ACE complementation
transformant merely needs to be restreaked onto minimal agar
media lacking uracil, and those colonies that grow puriﬁed by
restreaking. The extra effort, therefore, equates to the time it takes
for uracil prototrophic colonies to develop, ca. 2e3 days in the case
of C. difﬁcile for instance (Fig. 2). The efﬁciency of ACE is such that
success is assured and moreover, false positives cannot arise as
reversion of the pyrE deletion is impossible. Although the effort
required for ACE-mediated complementation is minimal, the
beneﬁts are considerable. It avoids the phenotypic effects
frequently observed with high copy number plasmids and dis-
penses with the need to add antibiotic to ensure the retention of
the complementing plasmid. Such antibiotic addition can affect
phenotype [see 39] and necessitate the inclusion in any pheno-
typic assessments of the mutant a vector only control. Moreover,
the pyrE allele represents an ideal position where other applica-
tion speciﬁc modules may be inserted into clostridial genomes,
such as a sigma factor to allow deployment of a mariner trans-
poson [55], hydrolases for degrading complex carbohydrates [48],
therapeutic genes in cancer delivery vehicles [56] or the addition
of an ermB gene to improve the reproducibility of the virulence of
the NAP1/B1/027 epidemic strain R20291 in the hamster model of
infection [57].
The beneﬁts of the presence of the pyrE locus are such, that
there is a rational argument for using pyrE mutant hosts, and their
cognate ACE correction vectors with any particular mutagen,
including the ClosTron and any of the alternative negative selection
markers developed in recent years. These include the E. coli genes
codA (cytosine deaminase) and mazF (mRNA interferase) exempli-
ﬁed in C. difﬁcile [38] and C. acetobutylicum [13,58], respectively,
and the Thermoanaerobacterium saccharolyticum tdk (thymidylate
synthetase) and Clostridium thermocellum hpt (hypoxanthine
phosphoribosyl transferase) genes, which were used to make
knock-outs in C. thermocellum [59]. The use of pyrE host would also
ﬁnd utility in the recently published recombineering approach
developed for use in C. acetobutylicum and C. beijerinckii [60], as
well as allelic exchange mutants made using CRISPR genome
editing [61e63].
A suite of pyrE ACE vectors are available (Fig. 3) to either: correct
the mutant pyrE allele of deletion mutants made in either C. difﬁcile
or C. acetobutylicum. In C. difﬁcile strains the correction vectors for
strains 630DermDpyrE and R20291DpyrE are pMTL-YN1 and pMTL-
YN2, respectively. Those vectors that allow the simultaneous
complementation of an inactivated gene concomitant with resto-
ration of prototrophy are pMTL-YN1C and pMTL-YN2C, while those
that bring about overexpression of the complementing gene are
pMTL-YN1X and pMTL-YN2X. In C. acetobutylicum the respective
vectors are pMTL-ME6 (correction vector), pMTL-ME6C (comple-
mentation vector) and pMTLME6X (overexpression vector).
Equivalent vector sets, are available in this laboratory for
C. beijerinckii, C. botulinum, C. perfringens, C. sporogenes, C. pas-
teurianum, Clostridium ljungdahlii and C. autoethanogenum. Further
Fig. 2. Comparison of the steps required for complementation using ACE integration [A] or autonomous [B] vectors. Step are: (1) Plasmid construction; (2) Transfer to
clostridia (electroporation or conjugation); (3) development of transformant/transconjugant colonies on rich agar containing antibiotic relevant to the resistance gene present on
the plasmid backbone; (4) in the case of [A] only, restreaked on minimal media lacking uracil (only double crossover integrants grow) and antibiotic supplementation, and; (5)
puriﬁcation of complemented clonal populations, in the case of [A] on rich media containing antibiotic to select for the plasmid, and in the case of [B] rich media containing
antibiotic. ACE integration [A] is characterised by being at appropriate gene dosage, requires no supplementing antibiotic as the complementing gene is entirely stable, this
eliminates antibiotic effects on phenotype and, therefore dispenses with the requirement for vector only control. The use of autonomous vectors [B] results in high gene dosage that
can affect phenotype, requires antibiotic supplementation to maintain the plasmid which can affect phenotype and necessitates the inclusion of an additional vector only control.
N.P. Minton et al. / Anaerobe 41 (2016) 104e112 109vectors are also under development for a number of other clos-
tridial species.
2.9. Creation of random mutant libraries through the mariner
transposon mutagenesis
One exempliﬁcation of the utility of ACE and the pyrE locus for
inserting application speciﬁc modules is that used to derive a
universal transposon system for Clostridium sp [55]. In early work,
we had demonstrated the utility of amariner based plasmid system
(pMTL-SC1) in C. difﬁcile [40] in which the mariner transposase
gene was placed under the control of the promoter (PtcdB) of the
C. difﬁcile toxin B gene, tcdB. This promoter (PtcdB) is exclusively
recognised by a specialised class of sigma factor, TcdR, which be-
longs to a family that is unique to a handful of toxinogenic clos-
tridial species [64]. As E. coli does not produce an analogous sigma
factor, the promoter is poorly recognised by this host, a feature that
prevents transposon activity in E. coli prior to transfer of the vector.
Avoidance of transposition activity in the donor strain prior to
transfer to the clostridial recipient is a desirable attribute as
transferred plasmids could potentially either become devoid of the
catP-based min-transposon or indeed in some way functionally
affected by its insertion into the vector at a new position. Essen-
tially, the system may be considered as a conditional expression
system, where transposase expression is limited to the clostridial
host.
As other clostridial species lack a functional equivalent to TcdR
we reasoned that if we were to introduce the encoding gene into
genome at the pyrE locus using ACE then the pMTL-SC1 transposonvector should be functional in the new host. Accordingly, the tcdR
gene was inserted into the genomes of both C. acetobutylicum and
C. sporogenes using the ACE complementation vector pMTL-ME6C
(section 2.7) and a functionally equivalent plasmid developed for
C. sporogenes [55]. Successful integrants were selected merely on
the basis of restoration of uracil prototrophy (see section 2.7). In
both cases, the genes were cloned without the tcdR promoter re-
gion and were therefore reliant on the upstream promoters
responsible for pyrE expression. This level of expression apparently
had no effect on the phenotype of the strains generated based on
the observed absence of any effects on growth rate, sporulation
frequency and measured metabolic products [55]. The level of
expression was, however, sufﬁcient for effective expression of tcdR,
as transposition of the min-transposon was readily detected at a
frequency of 2.6 (±0.6)  104 and 3.2 (±0.5)  104 in
C. acetobutylicum and C. sporogenes, respectively [55]. As was pre-
viously the case with C. difﬁcile, inverse PCR on the
C. acetobutylicum and C. sporogenes transposon mutants demon-
strated that just a single insertion had taken place in the over-
whelming majority of cases (98.3% and 96.7%, respectively) and
that insertion had taken place principally within protein coding
sequences (respectively, 83.6% and 79%). The latter frequency is
consistentwith the fact that 80% of the clostridial genome is protein
coding. The utility of the system was further exempliﬁed by the
isolation of mutants phenotypically affected in sporulation/germi-
nation as well as autotrophic strains which could no longer grow on
minimal media [55].
The utility of the system was further improved by the devel-
opment and deployment of a plasmid delivery vehicle that was
Fig. 3. The three types of ACE integration vectors used to restore the pyrE allele to wildtype in the pyrEmutant host in which a mutation (Gene X) has been made by allelic
exchange. Integration cassettes are modular and inserted between the SbfI and AscI sites of the pMTL80000 vectors. Each vector has a long (1200 bp) Right hand homology arm
(RHA) and a shorter (300 bp) left homology arm (LHA). The latter is composed of the 30-end of the pyrE gene, while former comprises the 1200 bp region of the chromosome from
immediately downstream of the pyrE gene. In the case of the ACE Correction vector [1], the 300 bp and 1200 bp regions are in effect a continuous 1500 bp region of homology to the
host chromosome in this region. In the case of the Complementation [2] and Overexpression [3] vectors, the two homology arms are separated by a region of DNA comprising a lacZ
containing multiple cloning site (MCS) region and a downstream transcriptional terminator (FT). The Expression vector additionally contains a strong promoter (Pfdx) from the
C. sporogenes ferredoxin gene immediately before the lacZ0 gene. Using the MCS, the complementation and expression plasmid variants allow delivery of a functional copy of a
knocked-out gene (Gene X) under the control of its native promoter, for complementation studies, or under the control of the strong promoter of the C. spororgenes ferredoxin gene
(Pfdx), to allow an assessment of the effect of overexpressing the gene. In every case, integration if the ACE plasmid is initially via the longer RHA. Subsequent plasmid excision via
the LHA restores the pyrE allele to wildtype, allowing the former pyrE minus host to grow on minimal media lacking uracil.
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inducible promoter upstream of the pCB102 replicon. In the
absence of inducer the plasmid replicated normally. Upon addition
of IPTG, the plasmid (pMTL-YZ14) was rapidly lost: 80% in the case
of C. sporogenes and 100% in the case of C. acetobutylicum [55]. The
ability to rapidly lose the plasmid represented a considerable
improvement on pMTL-SC1, which was based on a pseudo-suicide
replicon and required a minimum of two passages of the recipient
bacteria to eradicate the Himar1 C9 transposase encoding plasmid.
The conditional vector has been shown to function effectively in
C. beijerinckii, C. botulinum and C. autoethanogenum but cannot be
used in C. difﬁcile (unpublished data). The latter observation is
because C. difﬁcile apparently does not take up IPTG. Functionality
in this particular clostridial host, or indeed any clostridial host
where a similar obstacle is encountered, will require the substitu-
tion of the IPTG inducible promoter with a different inducible
system, eg., the anhydrotetracycline inducible system exempliﬁed
in C. difﬁcile [65] or the lactose inducible system of C. perfringens
[66].3. Roadmap outcome
The key steps involved in the roadmap are summarised in Fig. 4.
Through implementation of the outlined procedures it is possible to
formulate a generally applicable toolbox for use in potentially any
Clostridium spp. To date, provided DNA transfer is obtained, we
have not encountered any clostridial species where this technology
cannot be applied. Thus, all clostridia contain the requisite pyrim-
idine pathway, the inactivation of which leads to uracil auxotrophy
and FOAR. ClosTron technology appears universally applicable and
at least one, most usually all, of the modular replicons available
have proven functional. In the unlikely event that they are not, the
modular nature of our vectors mean that a new functional replicon
can be rapidly substituted. Aside from the use of pyrE alleles as
counter selection markers, their most useful attribute resides in the
use of the mutant allele, in combination with ACE, as a locus for
genome insertion, be it for complementation studies or for the
insertion of application speciﬁc modules. The case for using such
hosts for all mutational studies, regardless of the mutagen, is
Fig. 4. Schematic representation of Roadmap stages. For details refer to relevant section (2.1 to 2.9) in the text.
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